Menu

Image of the Day: Landing Blows

The smashing mantis shrimp is strategic in its attack on sea snails.  

Jun 18, 2018
Sukanya Charuchandra

A smashing mantis shrimp (Neogonodactylus bredini) hammers a Cerithium spp. snail. This video includes the last few strikes to the apex before the mantis shrimp started eating. VIDEO COURTESY OF THE PATEK LAB.Scientists have learned that the Caribbean rock mantis shrimp (Neogonodactylus bredini) is anything but slapdash in its approach to decimating its shell-covered food morsel. In a study reported in the Journal of Experimental Biology on June 14, researchers detail its tactics. 

Researchers provided the mantis shrimp with sea snails of various shapes and saw that it would switch how it pummeled its prey depending on the shell’s thickness.

R.L. Crane et al., “Smashing mantis shrimp strategically impact shells,” J Exp Biol, doi:10.1242/jeb.176099, 2018.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.